NTRK-rearranged Spindle Cell Neoplasm: Initial Observation of Imaging Appearance and Clinicopathologic Correlation

Overview

Journal Clin Imaging

Publisher Elsevier

Specialty Radiology

Date 2024 Apr 17

PMID 38631176

Authors

Matthew Spano

Cecilia Davis-Hayes

Meera Hameed

Ryma Benayed

Sinchun Hwang

Affiliations

Soon will be listed here.

Abstract

Objective: To explore pre-treatment imaging findings of neurotrophic tyrosine receptor kinase (NTRK)-rearranged spindle cell neoplasm, an emerging group of molecularly defined soft tissue tumors and summarize the clinical course, including TRK inhibitor therapy response.

Materials And Methods: This retrospective study included 8 women and 4 men with NTRK-rearranged spindle cell neoplasm (median age, 35.5 years, range, 0-66). Available pre-treatment MRI, CT, PET, and US imaging were reviewed. Tumor histology and the patients' clinical course were reviewed.

Results: Primary tumors were located within the soft tissue, lungs, kidney, and breast with soft tissue being the most prevalent site (n = 6). Pre-treatment MRI (n = 4) revealed linear hypointense signal foci and contrast enhancement in all patients with hemorrhage in half of the tumors. A tail sign (n = 1) and fluid levels (n = 1) were less frequent. Ultrasound showed well-marginated hypoechoic masses with internal flow. Primary tumors were all non-calcified on CT (4/4). Metastases were FDG-avid (4/4). Among the 8 patients who developed metastasis, 7 developed pulmonary metastases. All four patients who received NTRK inhibitor therapy showed an initial decrease in tumor size or FDG uptake.

Conclusion: NTRK-rearranged neoplasms may occur as enhancing masses with linear hypointense signal foci on MRI and FDG avid metastases on PET. Pulmonary metastases were frequent in our study. Initial treatment response is observed in most patients.

References

Kobayashi H, Teramura Y, Yamashita K, Makise N, Ae K, Tanaka S . Imaging findings of NTRK‑rearranged spindle cell neoplasms: A case series. Mol Clin Oncol. 2023; 18(3):14. PMC: 9926045. DOI: 10.3892/mco.2023.2610. View

Murphey M, Smith W, Smith S, Kransdorf M, Temple H . From the archives of the AFIP. Imaging of musculoskeletal neurogenic tumors: radiologic-pathologic correlation. Radiographics. 1999; 19(5):1253-80. DOI: 10.1148/radiographics.19.5.g99se101253. View

Eggert A, Grotzer M, Ikegaki N, Evans A, Brodeur G . Expression of the neurotrophin receptor TrkA down-regulates expression and function of angiogenic stimulators in SH-SY5Y neuroblastoma cells. Cancer Res. 2002; 62(6):1802-8. View

Overfield C, Edgar M, Wessell D, Wilke B, Garner H . NTRK-rearranged spindle cell neoplasm of the lower extremity: radiologic-pathologic correlation. Skeletal Radiol. 2022; 51(8):1707-1713. DOI: 10.1007/s00256-022-03995-w. View

Drilon A, Laetsch T, Kummar S, Dubois S, Lassen U, Demetri G . Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children. N Engl J Med. 2018; 378(8):731-739. PMC: 5857389. DOI: 10.1056/NEJMoa1714448. View

Agaram N, Zhang L, Sung Y, Chen C, Chung C, Antonescu C . Recurrent NTRK1 Gene Fusions Define a Novel Subset of Locally Aggressive Lipofibromatosis-like Neural Tumors. Am J Surg Pathol. 2016; 40(10):1407-16. PMC: 5023452. DOI: 10.1097/PAS.0000000000000675. View

Suurmeijer A, Dickson B, Swanson D, Zhang L, Sung Y, Huang H . The histologic spectrum of soft tissue spindle cell tumors with NTRK3 gene rearrangements. Genes Chromosomes Cancer. 2019; 58(11):739-746. PMC: 6733642. DOI: 10.1002/gcc.22767. View

Wasa J, Nishida Y, Tsukushi S, Shido Y, Sugiura H, Nakashima H . MRI features in the differentiation of malignant peripheral nerve sheath tumors and neurofibromas. AJR Am J Roentgenol. 2010; 194(6):1568-74. DOI: 10.2214/AJR.09.2724. View

Chao M . Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat Rev Neurosci. 2003; 4(4):299-309. DOI: 10.1038/nrn1078. View

10.

Lefkowitz R, Landa J, Hwang S, Zabor E, Moskowitz C, Agaram N . Myxofibrosarcoma: prevalence and diagnostic value of the "tail sign" on magnetic resonance imaging. Skeletal Radiol. 2013; 42(6):809-18. PMC: 4082187. DOI: 10.1007/s00256-012-1563-6. View

11.

Patel V, Naik S, Naidich D, Travis W, Weingarten J, Lazzaro R . A practical algorithmic approach to the diagnosis and management of solitary pulmonary nodules: part 1: radiologic characteristics and imaging modalities. Chest. 2013; 143(3):825-839. DOI: 10.1378/chest.12-0960. View

12.

Takamiya A, Ishibashi Y, Makise N, Hirata M, Ushiku T, Tanaka S . Imaging characteristics of NTRK-rearranged spindle cell neoplasm of the soft tissue: A case report. J Orthop Sci. 2022; 28(6):1580-1583. DOI: 10.1016/j.jos.2021.11.002. View

13.

Ainsworth K, Chavhan G, Gupta A, Hopyan S, Taylor G . Congenital infantile fibrosarcoma: review of imaging features. Pediatr Radiol. 2014; 44(9):1124-9. DOI: 10.1007/s00247-014-2957-5. View

14.

Demetri G, Antonescu C, Bjerkehagen B, Bovee J, Boye K, Chacon M . Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network. Ann Oncol. 2020; 31(11):1506-1517. PMC: 7985805. DOI: 10.1016/j.annonc.2020.08.2232. View

15.

Lagadec C, Meignan S, Adriaenssens E, Foveau B, Vanhecke E, Romon R . TrkA overexpression enhances growth and metastasis of breast cancer cells. Oncogene. 2009; 28(18):1960-70. DOI: 10.1038/onc.2009.61. View

16.

Ledoux P, Kind M, Le Loarer F, Stoeckle E, Italiano A, Tirode F . Abnormal vascularization of soft-tissue sarcomas on conventional MRI: Diagnostic and prognostic values. Eur J Radiol. 2019; 117:112-119. DOI: 10.1016/j.ejrad.2019.06.007. View

17.

Vaishnavi A, Le A, Doebele R . TRKing down an old oncogene in a new era of targeted therapy. Cancer Discov. 2014; 5(1):25-34. PMC: 4293234. DOI: 10.1158/2159-8290.CD-14-0765. View